Testosterone Therapy and Cardiovascular Risk

Dr. Abraham Morgentaler, an Associate Clinical Professor of Urology at Harvard Medical School and affiliated with Beth Israel Deaconess Medical Center, in Boston, MA, along with his coauthors, explore and clarify in the February 2015 issue of Mayo Clinic Proceedings, the value of testosterone therapy in men, and in particular the issue of cardiovascular risk. They debunk an article of questionable validity that raised concerns regarding cardiovascular risks among the public, and note that although there is not a definitive answer yet, there does appear to be benefits from testosterone therapy and no compelling evidence of cardiovascular risk in the scientific literature.